3//SEC Filing
Flagship Pioneering Fund VII, L.P. 3
Accession 0000950170-24-015184
CIK 0001770121other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:00 PM ET
Size
7.7 KB
Accession
0000950170-24-015184
Insider Transaction Report
Form 3
Holdings
- (indirect: By Flagship Pioneering Fund VII, L.P.)
Pre-Funded Warrants to purchase Common Stock
Exercise: $0.00From: 2024-02-12→ Common Stock (2,727,272 underlying)
Footnotes (2)
- [F1]On February 12, 2024, pursuant to an underwritten public offering by the Issuer, Flagship Pioneering Fund VII, L.P. ("Flagship Fund VII") acquired pre-funded warrants to purchase 2,727,272 shares of Common Stock (the "Pre-Funded Warrants") at a purchase price of $5.4999 per Pre-Funded Warrant. The Pre-Funded Warrants do not have an expiration date.
- [F2]Shares held by Flagship Fund VII. Flagship Pioneering Fund VII General Partner LLC ("Flagship Fund VII GP") is the general partner of Flagship Fund VII. Flagship Pioneering, Inc. ("Flagship Pioneering") is the manager of Flagship Fund VII GP. Noubar B. Afeyan, Ph.D. is the Chief Executive Officer, sole shareholder and director of Flagship Pioneering. Each of the reporting persons except Flagship Fund VII disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.
Documents
Issuer
Sana Biotechnology, Inc.
CIK 0001770121
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001805916
Filing Metadata
- Form type
- 3
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 4:00 PM ET
- Size
- 7.7 KB